XFRA NEW INSTRUMENTS AVAILABLE ON 24.06.2025

Realtime	Geld	Brief	Zeit
	9,850	10,100	22:45

Realtime

Geld

Brief

Zeit

9,850

10,100

22:45

XFRA NEW INSTRUMENTS AVAILABLE ON 24.06.2025

The following instruments on XETRA do have their first trading 24.06.2025
Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 24.06.2025

Aktien

1 NL0015002J37 JBS N.V.
2 AU0000400616 Virgin Australia Holdings Ltd.
3 US1421521071 Caris Life Sciences Inc.
4 US15117F8804 Cellectar Biosciences Inc.
5 KYG2545C1042 Crescent Biopharma Inc.

6 CA3194101067 First Canadian Grahite Inc.
7 KYG3472Y1199 FIH Mobile Ltd.
8 CA75103L3092 Rakovina Therapeutics Inc.

Anleihen/ETF

1 XS3102006031 Al Mi'yar Capital S.A.
2 EU000A4EB337 Europäische Union
3 NO0013289397 Gondola Midco AS
4 US594972AN17 MicroStrategy Inc.
5 XS3094548123 OTP Jelzálogbank Részvénytársaság
6 XS3098982815 SNB Funding Ltd.
7 USN88808AE50 Trivium Packaging Finance B.V.
8 US92939UAP12 WEC Energy Group Inc.
9 XS2903447519 Hyundai Capital America
10 XS3079581479 Intesa Sanpaolo S.p.A.
11 XS3077018714 Nexi S.p.A.
12 DE000HEL4AF3 Landesbank Hessen-Thüringen Girozentrale
13 IE000CO3P697 First Trust Vest U.S. Equity Max Buffer UCITS ETF
14 IE000HFBJ0U0 First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF

Solarbranche vor dem Mega-Comeback?

Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:

Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
hina bremst Preisdumping & pusht massiv den Ausbau

Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!

Hier klicken

Zeit	Aktuelle Nachrichten
13.08.	Caris Life Sciences stock price target raised to $37 by BofA on strong ASP growth
13.08.	Caris Life Sciences stock price target raised to $45 from $38 at BTIG
13.08.	BTIG hebt Kursziel für Caris Life Sciences auf 45 $ an
13.08.	Caris Life Sciences stock price target raised to $40 from $33 at Evercore ISI
13.08.	Evercore ISI hebt Kursziel für Caris Life Sciences auf 40 US-Dollar an

Zeit

Aktuelle Nachrichten

13.08.

Caris Life Sciences stock price target raised to $37 by BofA on strong ASP growth

13.08.

Caris Life Sciences stock price target raised to $45 from $38 at BTIG

13.08.

BTIG hebt Kursziel für Caris Life Sciences auf 45 $ an

13.08.

Caris Life Sciences stock price target raised to $40 from $33 at Evercore ISI

13.08.

Evercore ISI hebt Kursziel für Caris Life Sciences auf 40 US-Dollar an

Zeit	Aktuelle Nachrichten
24.09.	Cellectar Biosciences, Inc.: Cellectar and Evestia Clinical Announce Partnership to Support Auger-Emitting Radiopharmaceutical Clinical Trial in Triple-Negative Breast Cancer (TNBC)
11.09.	Cellectar Biosciences, Inc.: Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225
09.09.	Cellectar Biosciences, Inc.: Cellectar Biosciences to Participate at Oppenheimer 3rd Annual Targeted Radiopharmaceutical Therapies in Oncology Summit
14.08.	Cellectar signals NDA submission for iopofosine I-131 in WM by early 2026 amid accelerated approval focus
14.08.	Cellectar Biosciences GAAP EPS of -$3.39 beats by $0.31

Zeit

Aktuelle Nachrichten

24.09.

Cellectar Biosciences, Inc.: Cellectar and Evestia Clinical Announce Partnership to Support Auger-Emitting Radiopharmaceutical Clinical Trial in Triple-Negative Breast Cancer (TNBC)

11.09.

Cellectar Biosciences, Inc.: Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225

09.09.

Cellectar Biosciences, Inc.: Cellectar Biosciences to Participate at Oppenheimer 3rd Annual Targeted Radiopharmaceutical Therapies in Oncology Summit

14.08.

Cellectar signals NDA submission for iopofosine I-131 in WM by early 2026 amid accelerated approval focus

14.08.

Cellectar Biosciences GAAP EPS of -$3.39 beats by $0.31

Zeit	Aktuelle Nachrichten
Do	XFRA C68: WIEDERAUFNAHME/RESUMPTION	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen
27.08.	Stifel reiterates Buy rating on Crescent Biopharma stock at $28 target
25.08.	Jefferies startet Coverage für Crescent Biopharma mit Kaufempfehlung und hohem Kursziel
25.08.	Jefferies initiates coverage on Crescent Biopharma stock with Buy rating
31.07.	Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights	Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors Recent Leadership Appointments Bring... ► Artikel lesen

Zeit

Aktuelle Nachrichten

XFRA C68: WIEDERAUFNAHME/RESUMPTION

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen

27.08.

Stifel reiterates Buy rating on Crescent Biopharma stock at $28 target

25.08.

Jefferies startet Coverage für Crescent Biopharma mit Kaufempfehlung und hohem Kursziel

25.08.

Jefferies initiates coverage on Crescent Biopharma stock with Buy rating

31.07.

Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors Recent Leadership Appointments Bring...
► Artikel lesen

Zeit	Aktuelle Nachrichten
24.09.	FIH (02038): NEXT DAY DISCLOSURE RETURN
18.09.	FIH (02038): LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF INTERIM REPORT 2025 AND ARRANGEMENT OF ELECTRONIC DISSEMINATION ...
18.09.	FIH (02038): LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF INTERIM REPORT 2025 AND ARRANGEMENT OF ELECTRONIC DISSEMINATION ...
18.09.	FIH (02038): INTERIM REPORT 2025
12.09.	FIH (02038): NEXT DAY DISCLOSURE RETURN

Zeit

Aktuelle Nachrichten

24.09.

FIH (02038): NEXT DAY DISCLOSURE RETURN

18.09.

FIH (02038): LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF INTERIM REPORT 2025 AND ARRANGEMENT OF ELECTRONIC DISSEMINATION ...

18.09.

FIH (02038): LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF INTERIM REPORT 2025 AND ARRANGEMENT OF ELECTRONIC DISSEMINATION ...

18.09.

FIH (02038): INTERIM REPORT 2025

12.09.

FIH (02038): NEXT DAY DISCLOSURE RETURN

Zeit	Aktuelle Nachrichten
22:42	First Canadian Graphite Inc: First Canadian talks Volt Carbon's second U.S. patent
14:34	First Canadian Graphite Inc.: Congratulations to Volt Carbon Technologies on Second U.S. Patent and Graphene Achievement
03.09.	First Canadian Graphite Inc: First Canadian talks up Berkwood resource estimate
02.09.	First Canadian Graphite Inc. Corporate Update
29.08.	First Canadian Graphite Inc: First Canadian 4,672,500-share private placement

Zeit

Aktuelle Nachrichten

22:42

First Canadian Graphite Inc: First Canadian talks Volt Carbon's second U.S. patent

14:34

First Canadian Graphite Inc.: Congratulations to Volt Carbon Technologies on Second U.S. Patent and Graphene Achievement

03.09.

First Canadian Graphite Inc: First Canadian talks up Berkwood resource estimate

02.09.

First Canadian Graphite Inc. Corporate Update

29.08.

First Canadian Graphite Inc: First Canadian 4,672,500-share private placement

Zeit	Aktuelle Nachrichten
14:58	JBS to invest in Paraguay poultry production
Do	JBS returns to Paraguay with $70 million investment, including plant purchase
Mo	Greenpeace links JBS to cattle illegally raised in indigenous lands
25.09.	Greenpeace accuses Brazil's JBS of buying cattle illegally raised in indigenous lands
19.09.	Brazilian minister intervenes in JBS slave labor investigation

Zeit

Aktuelle Nachrichten

14:58

JBS to invest in Paraguay poultry production

JBS returns to Paraguay with $70 million investment, including plant purchase

Greenpeace links JBS to cattle illegally raised in indigenous lands

25.09.

Greenpeace accuses Brazil's JBS of buying cattle illegally raised in indigenous lands

19.09.

Brazilian minister intervenes in JBS slave labor investigation

Zeit	Aktuelle Nachrichten
29.08.	Rakovina Therapeutics reports Q2 results
29.08.	Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update	VANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies... ► Artikel lesen
26.08.	Rakovina Therapeutics Inc: Rakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on Cancer Research and Apoptosis
12.08.	Rakovina Therapeutics Inc (2): Rakovina Therapeutics signs LOI for JV with NanoPalm
12.08.	Rakovina Therapeutics Inc: Rakovina Therapeutics and NanoPalm Ltd. Sign Letter of Intent to Form Joint Venture Leveraging AI-Discovered Oncology Therapies and Novel Lipid Nanoparticle Delivery Technologies	VANCOUVER, British Columbia and RIYADH, Saudi Arabia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company... ► Artikel lesen

Zeit

Aktuelle Nachrichten

29.08.

Rakovina Therapeutics reports Q2 results

29.08.

Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies...
► Artikel lesen

26.08.

Rakovina Therapeutics Inc: Rakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on Cancer Research and Apoptosis

12.08.

Rakovina Therapeutics Inc (2): Rakovina Therapeutics signs LOI for JV with NanoPalm

12.08.

Rakovina Therapeutics Inc: Rakovina Therapeutics and NanoPalm Ltd. Sign Letter of Intent to Form Joint Venture Leveraging AI-Discovered Oncology Therapies and Novel Lipid Nanoparticle Delivery Technologies

VANCOUVER, British Columbia and RIYADH, Saudi Arabia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Mi	VIRGIN AUSTRALIA HOLDINGS LIMITED: 2025 Notice of Annual General Meeting
24.09.	Flottenerneuerung bei Virgin Australia Regional Airlines
22.09.	Erstmals in Australien: Virgin Australia erlaubt Haustiere in der Kabine
16.09.	Virgin Australia apologises after breastfeeding mum ejected from lounge
12.09.	VIRGIN AUSTRALIA HOLDINGS LIMITED: 2025 AGM Date

Zeit

Aktuelle Nachrichten

VIRGIN AUSTRALIA HOLDINGS LIMITED: 2025 Notice of Annual General Meeting

24.09.

Flottenerneuerung bei Virgin Australia Regional Airlines

22.09.

Erstmals in Australien: Virgin Australia erlaubt Haustiere in der Kabine

16.09.

Virgin Australia apologises after breastfeeding mum ejected from lounge

12.09.

VIRGIN AUSTRALIA HOLDINGS LIMITED: 2025 AGM Date

Unternehmen / Aktien	Kurs	%
CARIS LIFE SCIENCES INC	25,600	+0,79 %
CELLECTAR BIOSCIENCES INC	5,720	-1,72 %
CRESCENT BIOPHARMA INC	9,250	+1,09 %
FIH MOBILE LTD	2,020	-0,98 %
FIRST CANADIAN GRAPHITE INC	0,125	-2,34 %
JBS NV	12,500	-0,79 %
RAKOVINA THERAPEUTICS INC	0,211	-2,31 %
VIRGIN AUSTRALIA HOLDINGS LIMITED	2,040	0,00 %

Unternehmen / Aktien

Kurs

CARIS LIFE SCIENCES INC

25,600

+0,79 %

CELLECTAR BIOSCIENCES INC

5,720

-1,72 %

CRESCENT BIOPHARMA INC

9,250

+1,09 %

FIH MOBILE LTD